# Entrée Capital

Entrée Capital is a Venture Capital based in Tel Aviv, Israel.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Tel Aviv, Israel
- **Region:** Middle East
- **Address:** Tel Aviv, Israel
- **Assets under management:** $1.5B (per firm website)
- **Website:** entreecap.com
- **LinkedIn:** https://www.linkedin.com/company/entree-capital

## Regulatory record

- **Reports private funds:** No

## About

Entrée Capital is a venture capital firm run by a team of former serial founders. They manage $1.5bn across a number of funds, with offices in Tel Aviv, London and New York. They partner with exceptional founders on big challenges spanning Software, Fintech, Deeptech, AI and Blockchain through to the reinvention of old industries.

## Sectors

- Enterprise Software
- AI/ML
- FinTech
- Crypto
- Digital Health
- SpaceTech

## Offices

- London, United Kingdom
- New York, United States

## People

- Aviad (Avi) Eyal — Co-Founder and Managing Partner
- Ran Achituv — General Partner
- Eran Bielski — General Partner
- Yoni Osherov — General Partner
- Saul Levin — Partner

## Questions

### Who makes investment decisions at Entrée Capital?

Aviad Eyal leads the partnership as co-founder and Managing Partner. General Partners Ran Achituv, Eran Bielski, and Yoni Osherov complete the senior investment committee. Tomer Niv directs the crypto practice, while Entrée Bio is led separately by Yael Gruenbaum-Cohen with advisory from John Maraganore (per firm website).

### How does Entrée Capital source its deals?

Entrée's partners are former serial founders and operators. Avi Eyal provides first institutional capital to several companies, giving rise to a repeat-founder network. The firm also runs SigmaLabs, a non-profit accelerator, which serves as a top-of-funnel for Israeli seed-stage deal flow. Its in-house data team, led by a VP of Data, systematically tracks the early-stage ecosystem.

### Does Entrée Capital do follow-on investments in portfolio companies?

Yes. The firm invests from Seed to Growth and reserves capital for follow-on rounds. Its March 2025 $300M fundraise was explicitly structured to back companies across stages, signaling continued appetite for multi-stage support (per firm website, March 2025).

### What is Entrée Capital's geographic focus?

The firm operates from Tel Aviv, London, and New York. Its portfolio is concentrated in Israel while extending into the United States (Stripe, PillPack, Coupang) and Europe (Deliveroo). The London office anchors its European deal flow.

### How is Entrée Capital's life science investing structured?

Entrée runs a dedicated life-science vehicle called Entrée Bio, co-founded by Yael Gruenbaum-Cohen, a former aMoon Partner with a DMD and Ph.D. in molecular genetics. The advisory bench includes John Maraganore, the founding CEO of Alnylam Pharmaceuticals, giving the firm specialized biotech expertise separate from its core tech venture funds.

### What is Entrée Capital's relationship with monday.com?

Avi Eyal provided the first capital to monday.com and led the firm's investment. The company went public on Nasdaq in 2021. Yoni Osherov, who joined Entrée as a General Partner in 2025, was the Chief Revenue Officer at monday.com and helped scale it from $10M to over $1B in ARR (per firm website).

### Does Entrée Capital manage a dedicated crypto fund?

The firm does not publicly market a standalone crypto fund, but it has a dedicated crypto strategy run by Tomer Niv, a former eToro executive. The March 2025 $300M fundraise explicitly includes crypto as a core mandate pillar, signaling a formal allocation alongside AI and deep-tech.

## Related profiles

- [Entrada Ventures](https://altss.com/profile/entrada-ventures)
- [Entrepreneur First](https://altss.com/profile/entrepreneur-first)

---

Last updated: 2026-08-11T15:06:42.396Z

Canonical page: https://altss.com/profile/entree-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology